FDA's New Generic EpiPen Approval Exemplifies Progress on Drug Price Reform

Last week, FDA Commissioner Scott Gottlieb announced the approval of the first generic version of EpiPen, an injectable form of epinephrine frequently used in children to treat life-threatening allergies. On this and many other Trump administration health care initiatives, the consistent theme is lower prices through competition.